Invention Grant
- Patent Title: Embolizing sclerosing hydrogel
-
Application No.: US14483274Application Date: 2014-09-11
-
Publication No.: US09731043B2Publication Date: 2017-08-15
- Inventor: Sophie Lerouge , Giles Soulez , Ahmed Fatimi , Jean-Michel Coutu , Jean Raymond
- Applicant: Val-Chum Limited Partnership , Socovar S.E.C.
- Applicant Address: CA Montreal, Quebec CA Montreal, Quebec
- Assignee: VAL-CHUM, LIMITED PARTNERSHIP,SOCOVAR S.E.C.
- Current Assignee: VAL-CHUM, LIMITED PARTNERSHIP,SOCOVAR S.E.C.
- Current Assignee Address: CA Montreal, Quebec CA Montreal, Quebec
- Agency: Brinks Gilson & Lione
- Main IPC: A61K49/00
- IPC: A61K49/00 ; A01N43/04 ; A61L24/08 ; A61K31/167 ; A61K31/722 ; A61K45/06 ; A61K49/04 ; A61L24/00
Abstract:
A sclerosing embolizing hydrogel comprising from about 0.1% by weight to about 4.0% by weight of chitosan; from about 0.01M to about 1M of hydrochloric acid; from 0% by volume to about 40% by volume of iopamidol; from 0.5% by weight to about 25% by weight of β-glycerophosphate disodium salt; and from about 0.05% by weight to about 4% by weight of sodium tetradecyl sulphate. Also a kit for synthesizing the hydrogel and a method using the hydrogel to treat a vascular defect in a subject.
Public/Granted literature
- US20140377187A1 Embolizing Sclerosing Hydrogel Public/Granted day:2014-12-25
Information query
